Glycan-targeted virus-like nanoparticles for photodynamic therapy

Jin Kyu Rhee; Michael Baksh; Corwin Nycholat; James C. Paulson; Hiroaki Kitagishi; M. G. Finn

doi:10.1021/bm300578p

Glycan-targeted virus-like nanoparticles for photodynamic therapy

Jin Kyu Rhee
, Michael Baksh
, Corwin Nycholat
, James C. Paulson
, Hiroaki Kitagishi
, M. G. Finn

Department of Food Science & Biotechnology

Research output: Contribution to journal › Article › peer-review

94 Scopus citations

Abstract

Virus-like particles (VLPs) have proven to be versatile platforms for chemical and genetic functionalization for a variety of purposes in biomedicine, catalysis, and materials science. We describe here the simultaneous modification of the bacteriophage Qβ VLP with a metalloporphyrin derivative for photodynamic therapy and a glycan ligand for specific targeting of cells bearing the CD22 receptor. This application benefits from the presence of the targeting function and the delivery of a high local concentration of singlet oxygen-generating payload.

Original language	English
Pages (from-to)	2333-2338
Number of pages	6
Journal	Biomacromolecules
Volume	13
Issue number	8
DOIs	https://doi.org/10.1021/bm300578p
State	Published - 13 Aug 2012

Access to Document

10.1021/bm300578p

Cite this

@article{20f5733ebc6a457b97a422c215905434,

title = "Glycan-targeted virus-like nanoparticles for photodynamic therapy",

abstract = "Virus-like particles (VLPs) have proven to be versatile platforms for chemical and genetic functionalization for a variety of purposes in biomedicine, catalysis, and materials science. We describe here the simultaneous modification of the bacteriophage Qβ VLP with a metalloporphyrin derivative for photodynamic therapy and a glycan ligand for specific targeting of cells bearing the CD22 receptor. This application benefits from the presence of the targeting function and the delivery of a high local concentration of singlet oxygen-generating payload.",

author = "Rhee, \{Jin Kyu\} and Michael Baksh and Corwin Nycholat and Paulson, \{James C.\} and Hiroaki Kitagishi and Finn, \{M. G.\}",

year = "2012",

month = aug,

day = "13",

doi = "10.1021/bm300578p",

language = "English",

volume = "13",

pages = "2333--2338",

journal = "Biomacromolecules",

issn = "1525-7797",

publisher = "American Chemical Society",

number = "8",

}

TY - JOUR

T1 - Glycan-targeted virus-like nanoparticles for photodynamic therapy

AU - Rhee, Jin Kyu

AU - Baksh, Michael

AU - Nycholat, Corwin

AU - Paulson, James C.

AU - Kitagishi, Hiroaki

AU - Finn, M. G.

PY - 2012/8/13

Y1 - 2012/8/13

N2 - Virus-like particles (VLPs) have proven to be versatile platforms for chemical and genetic functionalization for a variety of purposes in biomedicine, catalysis, and materials science. We describe here the simultaneous modification of the bacteriophage Qβ VLP with a metalloporphyrin derivative for photodynamic therapy and a glycan ligand for specific targeting of cells bearing the CD22 receptor. This application benefits from the presence of the targeting function and the delivery of a high local concentration of singlet oxygen-generating payload.

AB - Virus-like particles (VLPs) have proven to be versatile platforms for chemical and genetic functionalization for a variety of purposes in biomedicine, catalysis, and materials science. We describe here the simultaneous modification of the bacteriophage Qβ VLP with a metalloporphyrin derivative for photodynamic therapy and a glycan ligand for specific targeting of cells bearing the CD22 receptor. This application benefits from the presence of the targeting function and the delivery of a high local concentration of singlet oxygen-generating payload.

UR - https://www.scopus.com/pages/publications/84864992934

U2 - 10.1021/bm300578p

DO - 10.1021/bm300578p

M3 - Article

C2 - 22827531

AN - SCOPUS:84864992934

SN - 1525-7797

VL - 13

SP - 2333

EP - 2338

JO - Biomacromolecules

JF - Biomacromolecules

IS - 8

ER -

Glycan-targeted virus-like nanoparticles for photodynamic therapy

Abstract

Access to Document

Fingerprint

Cite this